Screener
AnaptysBio, Inc. ANAB Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total other expense, net | (18,207) | (11,746) |
| Loss before income taxes | (52,844) | (39,285) |
| Provision for income taxes | (40) | (44) |
| Net loss | (52,884) | (39,329) |
| Other comprehensive loss: | ||
| Unrealized loss on available-for-sale securities | (122) | (144) |
| Comprehensive loss | $(53,006) | $(39,473) |
| Net loss per common share: |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s net income?
- AnaptysBio, Inc. (ANAB) reported net income of -$52.88M in Q1 2026.
- How has AnaptysBio, Inc.'s net income changed year-over-year?
- AnaptysBio, Inc.'s net income decreased by 34.5% year-over-year, from -$39.33M to -$52.88M.
- What is the long-term trend for AnaptysBio, Inc.'s net income?
- Over 3 years (2021 to 2024), AnaptysBio, Inc.'s net income has grown at a 36.0% compound annual growth rate (CAGR), from -$57.8M to -$145.23M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about AnaptysBio, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude